nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Oedema—Temsirolimus—kidney cancer	0.00298	0.00301	CcSEcCtD
Propericiazine—Infection—Temsirolimus—kidney cancer	0.00296	0.00299	CcSEcCtD
Propericiazine—Jaundice—Sorafenib—kidney cancer	0.00294	0.00297	CcSEcCtD
Propericiazine—Hyperglycaemia—Sunitinib—kidney cancer	0.00294	0.00297	CcSEcCtD
Propericiazine—Pneumonia—Sunitinib—kidney cancer	0.00292	0.00295	CcSEcCtD
Propericiazine—Cardiac disorder—Everolimus—kidney cancer	0.0029	0.00293	CcSEcCtD
Propericiazine—Dry mouth—Pazopanib—kidney cancer	0.00286	0.00289	CcSEcCtD
Propericiazine—Pulmonary embolism—Capecitabine—kidney cancer	0.00286	0.00289	CcSEcCtD
Propericiazine—Oedema—Pazopanib—kidney cancer	0.00281	0.00284	CcSEcCtD
Propericiazine—Infection—Pazopanib—kidney cancer	0.00279	0.00282	CcSEcCtD
Propericiazine—Nasal congestion—Paclitaxel—kidney cancer	0.00278	0.00281	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—kidney cancer	0.00276	0.00279	CcSEcCtD
Propericiazine—Hypokalaemia—Gemcitabine—kidney cancer	0.00275	0.00278	CcSEcCtD
Propericiazine—Hyperhidrosis—Pazopanib—kidney cancer	0.00271	0.00274	CcSEcCtD
Propericiazine—Insomnia—Temsirolimus—kidney cancer	0.0027	0.00272	CcSEcCtD
Propericiazine—Arrhythmia—Erlotinib—kidney cancer	0.00269	0.00272	CcSEcCtD
Propericiazine—Dyspnoea—Temsirolimus—kidney cancer	0.00266	0.00269	CcSEcCtD
Propericiazine—Somnolence—Temsirolimus—kidney cancer	0.00265	0.00268	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—kidney cancer	0.00256	0.00259	CcSEcCtD
Propericiazine—Vision blurred—Everolimus—kidney cancer	0.00256	0.00259	CcSEcCtD
Propericiazine—Constipation—Temsirolimus—kidney cancer	0.00255	0.00258	CcSEcCtD
Propericiazine—Tremor—Everolimus—kidney cancer	0.00254	0.00257	CcSEcCtD
Propericiazine—Insomnia—Pazopanib—kidney cancer	0.00254	0.00257	CcSEcCtD
Propericiazine—Erectile dysfunction—Vincristine—kidney cancer	0.00254	0.00256	CcSEcCtD
Propericiazine—Photosensitivity reaction—Vincristine—kidney cancer	0.00251	0.00254	CcSEcCtD
Propericiazine—Cardiac disorder—Sorafenib—kidney cancer	0.00251	0.00254	CcSEcCtD
Propericiazine—Dyspnoea—Pazopanib—kidney cancer	0.0025	0.00253	CcSEcCtD
Propericiazine—Agitation—Everolimus—kidney cancer	0.0025	0.00252	CcSEcCtD
Propericiazine—Somnolence—Pazopanib—kidney cancer	0.0025	0.00252	CcSEcCtD
Propericiazine—Angioedema—Everolimus—kidney cancer	0.00248	0.00251	CcSEcCtD
Propericiazine—Pneumonia—Vincristine—kidney cancer	0.00247	0.0025	CcSEcCtD
Propericiazine—Arrhythmia—Sorafenib—kidney cancer	0.00242	0.00245	CcSEcCtD
Propericiazine—Cardiac disorder—Sunitinib—kidney cancer	0.00242	0.00244	CcSEcCtD
Propericiazine—Photosensitivity—Capecitabine—kidney cancer	0.00237	0.00239	CcSEcCtD
Propericiazine—Hyperglycaemia—Gemcitabine—kidney cancer	0.00236	0.00238	CcSEcCtD
Propericiazine—Body temperature increased—Temsirolimus—kidney cancer	0.00236	0.00238	CcSEcCtD
Propericiazine—Pneumonia—Gemcitabine—kidney cancer	0.00234	0.00237	CcSEcCtD
Propericiazine—Arrhythmia—Sunitinib—kidney cancer	0.00233	0.00235	CcSEcCtD
Propericiazine—Hypokalaemia—Paclitaxel—kidney cancer	0.0023	0.00233	CcSEcCtD
Propericiazine—Dry mouth—Everolimus—kidney cancer	0.00226	0.00229	CcSEcCtD
Propericiazine—Oedema—Everolimus—kidney cancer	0.00222	0.00224	CcSEcCtD
Propericiazine—Increased appetite—Capecitabine—kidney cancer	0.00221	0.00223	CcSEcCtD
Propericiazine—Infection—Everolimus—kidney cancer	0.0022	0.00223	CcSEcCtD
Propericiazine—Hypersensitivity—Temsirolimus—kidney cancer	0.0022	0.00222	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—kidney cancer	0.00219	0.00222	CcSEcCtD
Propericiazine—Agranulocytosis—Gemcitabine—kidney cancer	0.00217	0.0022	CcSEcCtD
Propericiazine—Tachycardia—Everolimus—kidney cancer	0.00216	0.00219	CcSEcCtD
Propericiazine—Angioedema—Sorafenib—kidney cancer	0.00215	0.00218	CcSEcCtD
Propericiazine—Hyperhidrosis—Everolimus—kidney cancer	0.00214	0.00217	CcSEcCtD
Propericiazine—Oedema—Erlotinib—kidney cancer	0.00214	0.00216	CcSEcCtD
Propericiazine—Sweating increased—Paclitaxel—kidney cancer	0.00213	0.00215	CcSEcCtD
Propericiazine—Infection—Erlotinib—kidney cancer	0.00212	0.00215	CcSEcCtD
Propericiazine—Ethopropazine—BCHE—kidney cancer	0.00211	0.201	CrCbGaD
Propericiazine—Jaundice cholestatic—Doxorubicin—kidney cancer	0.0021	0.00212	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—kidney cancer	0.0021	0.00212	CcSEcCtD
Propericiazine—Angioedema—Sunitinib—kidney cancer	0.00207	0.0021	CcSEcCtD
Propericiazine—Hypotension—Everolimus—kidney cancer	0.00207	0.00209	CcSEcCtD
Propericiazine—Cardiac disorder—Vincristine—kidney cancer	0.00205	0.00207	CcSEcCtD
Propericiazine—Diarrhoea—Temsirolimus—kidney cancer	0.00204	0.00206	CcSEcCtD
Propericiazine—Insomnia—Everolimus—kidney cancer	0.002	0.00203	CcSEcCtD
Propericiazine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.002	0.00202	CcSEcCtD
Propericiazine—Weight increased—Paclitaxel—kidney cancer	0.00199	0.00201	CcSEcCtD
Propericiazine—Dyspnoea—Everolimus—kidney cancer	0.00198	0.002	CcSEcCtD
Propericiazine—Hyperglycaemia—Paclitaxel—kidney cancer	0.00197	0.00199	CcSEcCtD
Propericiazine—Somnolence—Everolimus—kidney cancer	0.00197	0.00199	CcSEcCtD
Propericiazine—Dry mouth—Sorafenib—kidney cancer	0.00196	0.00198	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—kidney cancer	0.00196	0.00198	CcSEcCtD
Propericiazine—Pneumonia—Paclitaxel—kidney cancer	0.00196	0.00198	CcSEcCtD
Propericiazine—Cardiac disorder—Gemcitabine—kidney cancer	0.00194	0.00196	CcSEcCtD
Propericiazine—Insomnia—Erlotinib—kidney cancer	0.00193	0.00196	CcSEcCtD
Propericiazine—Diarrhoea—Pazopanib—kidney cancer	0.00192	0.00194	CcSEcCtD
Propericiazine—Infection—Sorafenib—kidney cancer	0.00191	0.00193	CcSEcCtD
Propericiazine—Dyspnoea—Erlotinib—kidney cancer	0.00191	0.00193	CcSEcCtD
Propericiazine—Constipation—Vinblastine—kidney cancer	0.0019	0.00192	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—kidney cancer	0.0019	0.00192	CcSEcCtD
Propericiazine—Constipation—Everolimus—kidney cancer	0.0019	0.00192	CcSEcCtD
Propericiazine—Vomiting—Temsirolimus—kidney cancer	0.00189	0.00191	CcSEcCtD
Propericiazine—Hypokalaemia—Capecitabine—kidney cancer	0.00189	0.00191	CcSEcCtD
Propericiazine—Dry mouth—Sunitinib—kidney cancer	0.00189	0.00191	CcSEcCtD
Propericiazine—Rash—Temsirolimus—kidney cancer	0.00188	0.0019	CcSEcCtD
Propericiazine—Dermatitis—Temsirolimus—kidney cancer	0.00188	0.0019	CcSEcCtD
Propericiazine—Arrhythmia—Gemcitabine—kidney cancer	0.00187	0.00189	CcSEcCtD
Propericiazine—Oedema—Sunitinib—kidney cancer	0.00185	0.00187	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—kidney cancer	0.00184	0.00186	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—kidney cancer	0.00184	0.00186	CcSEcCtD
Propericiazine—Infection—Sunitinib—kidney cancer	0.00184	0.00186	CcSEcCtD
Propericiazine—Constipation—Erlotinib—kidney cancer	0.00183	0.00185	CcSEcCtD
Propericiazine—Asthma—Capecitabine—kidney cancer	0.0018	0.00181	CcSEcCtD
Propericiazine—Vomiting—Pazopanib—kidney cancer	0.00179	0.0018	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—kidney cancer	0.00177	0.168	CrCbGaD
Propericiazine—Rash—Pazopanib—kidney cancer	0.00177	0.00179	CcSEcCtD
Propericiazine—Nausea—Temsirolimus—kidney cancer	0.00177	0.00179	CcSEcCtD
Propericiazine—Dermatitis—Pazopanib—kidney cancer	0.00177	0.00179	CcSEcCtD
Propericiazine—Agitation—Vincristine—kidney cancer	0.00176	0.00178	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—kidney cancer	0.00175	0.00177	CcSEcCtD
Propericiazine—Body temperature increased—Everolimus—kidney cancer	0.00175	0.00177	CcSEcCtD
Propericiazine—Sweating increased—Capecitabine—kidney cancer	0.00175	0.00177	CcSEcCtD
Propericiazine—Infection—Dactinomycin—kidney cancer	0.00174	0.00176	CcSEcCtD
Propericiazine—Triflupromazine—BCHE—kidney cancer	0.00173	0.164	CrCbGaD
Propericiazine—Dyspnoea—Sorafenib—kidney cancer	0.00172	0.00173	CcSEcCtD
Propericiazine—Body temperature increased—Erlotinib—kidney cancer	0.00169	0.00171	CcSEcCtD
Propericiazine—Insomnia—Sunitinib—kidney cancer	0.00167	0.00169	CcSEcCtD
Propericiazine—Nausea—Pazopanib—kidney cancer	0.00167	0.00169	CcSEcCtD
Propericiazine—Dyspnoea—Sunitinib—kidney cancer	0.00165	0.00167	CcSEcCtD
Propericiazine—Constipation—Sorafenib—kidney cancer	0.00165	0.00166	CcSEcCtD
Propericiazine—Hypersensitivity—Vinblastine—kidney cancer	0.00164	0.00166	CcSEcCtD
Propericiazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.00164	0.00166	CcSEcCtD
Propericiazine—Weight increased—Capecitabine—kidney cancer	0.00163	0.00165	CcSEcCtD
Propericiazine—Hypersensitivity—Everolimus—kidney cancer	0.00163	0.00165	CcSEcCtD
Propericiazine—Cardiac disorder—Paclitaxel—kidney cancer	0.00162	0.00164	CcSEcCtD
Propericiazine—Hyperglycaemia—Capecitabine—kidney cancer	0.00162	0.00164	CcSEcCtD
Propericiazine—Pneumonia—Capecitabine—kidney cancer	0.00161	0.00163	CcSEcCtD
Propericiazine—Constipation—Sunitinib—kidney cancer	0.00158	0.0016	CcSEcCtD
Propericiazine—Oedema—Vincristine—kidney cancer	0.00157	0.00158	CcSEcCtD
Propericiazine—Arrhythmia—Paclitaxel—kidney cancer	0.00156	0.00158	CcSEcCtD
Propericiazine—Jaundice—Capecitabine—kidney cancer	0.00156	0.00158	CcSEcCtD
Propericiazine—Infection—Vincristine—kidney cancer	0.00156	0.00157	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—kidney cancer	0.00152	0.00154	CcSEcCtD
Propericiazine—Diarrhoea—Vinblastine—kidney cancer	0.00152	0.00154	CcSEcCtD
Propericiazine—Body temperature increased—Sorafenib—kidney cancer	0.00152	0.00154	CcSEcCtD
Propericiazine—Diarrhoea—Everolimus—kidney cancer	0.00152	0.00153	CcSEcCtD
Propericiazine—Hyperhidrosis—Vincristine—kidney cancer	0.00151	0.00153	CcSEcCtD
Propericiazine—Agranulocytosis—Capecitabine—kidney cancer	0.00149	0.00151	CcSEcCtD
Propericiazine—Oedema—Gemcitabine—kidney cancer	0.00149	0.0015	CcSEcCtD
Propericiazine—Infection—Gemcitabine—kidney cancer	0.00148	0.00149	CcSEcCtD
Propericiazine—Body temperature increased—Sunitinib—kidney cancer	0.00146	0.00148	CcSEcCtD
Propericiazine—Diarrhoea—Erlotinib—kidney cancer	0.00146	0.00148	CcSEcCtD
Propericiazine—Hypotension—Vincristine—kidney cancer	0.00146	0.00148	CcSEcCtD
Propericiazine—Vision blurred—Paclitaxel—kidney cancer	0.00144	0.00145	CcSEcCtD
Propericiazine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00144	0.00145	CcSEcCtD
Propericiazine—Tremor—Paclitaxel—kidney cancer	0.00143	0.00144	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—kidney cancer	0.00142	0.00144	CcSEcCtD
Propericiazine—Hypersensitivity—Sorafenib—kidney cancer	0.00142	0.00143	CcSEcCtD
Propericiazine—Insomnia—Vincristine—kidney cancer	0.00142	0.00143	CcSEcCtD
Propericiazine—Vomiting—Vinblastine—kidney cancer	0.00141	0.00143	CcSEcCtD
Propericiazine—Vomiting—Everolimus—kidney cancer	0.00141	0.00142	CcSEcCtD
Propericiazine—Agitation—Paclitaxel—kidney cancer	0.0014	0.00142	CcSEcCtD
Propericiazine—Rash—Everolimus—kidney cancer	0.0014	0.00141	CcSEcCtD
Propericiazine—Dermatitis—Everolimus—kidney cancer	0.0014	0.00141	CcSEcCtD
Propericiazine—Angioedema—Paclitaxel—kidney cancer	0.00139	0.00141	CcSEcCtD
Propericiazine—Hypotension—Gemcitabine—kidney cancer	0.00139	0.0014	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—kidney cancer	0.00139	0.0014	CcSEcCtD
Propericiazine—Hypersensitivity—Sunitinib—kidney cancer	0.00136	0.00138	CcSEcCtD
Propericiazine—Vomiting—Erlotinib—kidney cancer	0.00136	0.00137	CcSEcCtD
Propericiazine—Rash—Erlotinib—kidney cancer	0.00135	0.00136	CcSEcCtD
Propericiazine—Dermatitis—Erlotinib—kidney cancer	0.00135	0.00136	CcSEcCtD
Propericiazine—Insomnia—Gemcitabine—kidney cancer	0.00134	0.00136	CcSEcCtD
Propericiazine—Constipation—Vincristine—kidney cancer	0.00134	0.00135	CcSEcCtD
Propericiazine—Cardiac disorder—Capecitabine—kidney cancer	0.00133	0.00135	CcSEcCtD
Propericiazine—Dyspnoea—Gemcitabine—kidney cancer	0.00132	0.00134	CcSEcCtD
Propericiazine—Nausea—Vinblastine—kidney cancer	0.00132	0.00134	CcSEcCtD
Propericiazine—Somnolence—Gemcitabine—kidney cancer	0.00132	0.00133	CcSEcCtD
Propericiazine—Nausea—Everolimus—kidney cancer	0.00132	0.00133	CcSEcCtD
Propericiazine—Diarrhoea—Sorafenib—kidney cancer	0.00132	0.00133	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—kidney cancer	0.00129	0.00131	CcSEcCtD
Propericiazine—Arrhythmia—Capecitabine—kidney cancer	0.00128	0.0013	CcSEcCtD
Propericiazine—Constipation—Gemcitabine—kidney cancer	0.00127	0.00128	CcSEcCtD
Propericiazine—Nausea—Erlotinib—kidney cancer	0.00127	0.00128	CcSEcCtD
Propericiazine—Dry mouth—Paclitaxel—kidney cancer	0.00127	0.00128	CcSEcCtD
Propericiazine—Diarrhoea—Sunitinib—kidney cancer	0.00127	0.00128	CcSEcCtD
Propericiazine—Confusional state—Paclitaxel—kidney cancer	0.00125	0.00127	CcSEcCtD
Propericiazine—Oedema—Paclitaxel—kidney cancer	0.00124	0.00126	CcSEcCtD
Propericiazine—Body temperature increased—Vincristine—kidney cancer	0.00124	0.00125	CcSEcCtD
Propericiazine—Infection—Paclitaxel—kidney cancer	0.00124	0.00125	CcSEcCtD
Propericiazine—Vomiting—Sorafenib—kidney cancer	0.00122	0.00124	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—kidney cancer	0.00122	0.00123	CcSEcCtD
Propericiazine—Tachycardia—Paclitaxel—kidney cancer	0.00121	0.00123	CcSEcCtD
Propericiazine—Rash—Sorafenib—kidney cancer	0.00121	0.00123	CcSEcCtD
Propericiazine—Dermatitis—Sorafenib—kidney cancer	0.00121	0.00123	CcSEcCtD
Propericiazine—Hyperhidrosis—Paclitaxel—kidney cancer	0.0012	0.00122	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—kidney cancer	0.0012	0.00121	CcSEcCtD
Propericiazine—Vision blurred—Capecitabine—kidney cancer	0.00118	0.00119	CcSEcCtD
Propericiazine—Vomiting—Sunitinib—kidney cancer	0.00118	0.00119	CcSEcCtD
Propericiazine—Body temperature increased—Gemcitabine—kidney cancer	0.00117	0.00119	CcSEcCtD
Propericiazine—Tremor—Capecitabine—kidney cancer	0.00117	0.00118	CcSEcCtD
Propericiazine—Rash—Sunitinib—kidney cancer	0.00117	0.00118	CcSEcCtD
Propericiazine—Dermatitis—Sunitinib—kidney cancer	0.00117	0.00118	CcSEcCtD
Propericiazine—Hypotension—Paclitaxel—kidney cancer	0.00116	0.00117	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—kidney cancer	0.00116	0.00117	CcSEcCtD
Propericiazine—Hypersensitivity—Vincristine—kidney cancer	0.00115	0.00117	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—kidney cancer	0.00115	0.00116	CcSEcCtD
Propericiazine—Nausea—Sorafenib—kidney cancer	0.00114	0.00116	CcSEcCtD
Propericiazine—Insomnia—Paclitaxel—kidney cancer	0.00113	0.00114	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—kidney cancer	0.00111	0.00113	CcSEcCtD
Propericiazine—Dyspnoea—Paclitaxel—kidney cancer	0.00111	0.00112	CcSEcCtD
Propericiazine—Somnolence—Paclitaxel—kidney cancer	0.00111	0.00112	CcSEcCtD
Propericiazine—Rash—Dactinomycin—kidney cancer	0.00111	0.00112	CcSEcCtD
Propericiazine—Nausea—Sunitinib—kidney cancer	0.0011	0.00111	CcSEcCtD
Propericiazine—Diarrhoea—Vincristine—kidney cancer	0.00107	0.00108	CcSEcCtD
Propericiazine—Constipation—Paclitaxel—kidney cancer	0.00106	0.00108	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00106	0.00107	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—kidney cancer	0.00105	0.00106	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—kidney cancer	0.00104	0.00105	CcSEcCtD
Propericiazine—Dry mouth—Capecitabine—kidney cancer	0.00104	0.00105	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—kidney cancer	0.00104	0.00105	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—kidney cancer	0.00104	0.00105	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—kidney cancer	0.00103	0.00104	CcSEcCtD
Propericiazine—Confusional state—Capecitabine—kidney cancer	0.00103	0.00104	CcSEcCtD
Propericiazine—Oedema—Capecitabine—kidney cancer	0.00102	0.00103	CcSEcCtD
Propericiazine—Diarrhoea—Gemcitabine—kidney cancer	0.00102	0.00103	CcSEcCtD
Propericiazine—Infection—Capecitabine—kidney cancer	0.00101	0.00102	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—kidney cancer	0.00101	0.00102	CcSEcCtD
Propericiazine—Tachycardia—Capecitabine—kidney cancer	0.000996	0.00101	CcSEcCtD
Propericiazine—Vomiting—Vincristine—kidney cancer	0.000996	0.00101	CcSEcCtD
Propericiazine—Rash—Vincristine—kidney cancer	0.000987	0.000998	CcSEcCtD
Propericiazine—Hyperhidrosis—Capecitabine—kidney cancer	0.000987	0.000997	CcSEcCtD
Propericiazine—Dermatitis—Vincristine—kidney cancer	0.000987	0.000997	CcSEcCtD
Propericiazine—Body temperature increased—Paclitaxel—kidney cancer	0.000983	0.000994	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000963	0.000973	CcSEcCtD
Propericiazine—Hypotension—Capecitabine—kidney cancer	0.000954	0.000964	CcSEcCtD
Propericiazine—Vomiting—Gemcitabine—kidney cancer	0.000945	0.000955	CcSEcCtD
Propericiazine—Rash—Gemcitabine—kidney cancer	0.000937	0.000947	CcSEcCtD
Propericiazine—Dermatitis—Gemcitabine—kidney cancer	0.000936	0.000946	CcSEcCtD
Propericiazine—Nausea—Vincristine—kidney cancer	0.00093	0.00094	CcSEcCtD
Propericiazine—Insomnia—Capecitabine—kidney cancer	0.000923	0.000933	CcSEcCtD
Propericiazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000916	0.000926	CcSEcCtD
Propericiazine—Dyspnoea—Capecitabine—kidney cancer	0.00091	0.00092	CcSEcCtD
Propericiazine—Nausea—Gemcitabine—kidney cancer	0.000882	0.000892	CcSEcCtD
Propericiazine—Constipation—Capecitabine—kidney cancer	0.000873	0.000882	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—kidney cancer	0.00086	0.000869	CcSEcCtD
Propericiazine—Diarrhoea—Paclitaxel—kidney cancer	0.000851	0.00086	CcSEcCtD
Propericiazine—Domperidone—ABCB1—kidney cancer	0.000837	0.0795	CrCbGaD
Propericiazine—Chlorpromazine—BCHE—kidney cancer	0.000834	0.0792	CrCbGaD
Propericiazine—Arrhythmia—Doxorubicin—kidney cancer	0.000827	0.000836	CcSEcCtD
Propericiazine—Body temperature increased—Capecitabine—kidney cancer	0.000807	0.000816	CcSEcCtD
Propericiazine—Vomiting—Paclitaxel—kidney cancer	0.000791	0.000799	CcSEcCtD
Propericiazine—Rash—Paclitaxel—kidney cancer	0.000784	0.000793	CcSEcCtD
Propericiazine—Dermatitis—Paclitaxel—kidney cancer	0.000784	0.000792	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—kidney cancer	0.00076	0.000768	CcSEcCtD
Propericiazine—Hypersensitivity—Capecitabine—kidney cancer	0.000752	0.00076	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—kidney cancer	0.000741	0.000749	CcSEcCtD
Propericiazine—Nausea—Paclitaxel—kidney cancer	0.000739	0.000747	CcSEcCtD
Propericiazine—Diarrhoea—Capecitabine—kidney cancer	0.000698	0.000706	CcSEcCtD
Propericiazine—Triflupromazine—ABCB1—kidney cancer	0.000677	0.0644	CrCbGaD
Propericiazine—Dry mouth—Doxorubicin—kidney cancer	0.000671	0.000678	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—kidney cancer	0.000663	0.000671	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—kidney cancer	0.000658	0.000665	CcSEcCtD
Propericiazine—Infection—Doxorubicin—kidney cancer	0.000654	0.000661	CcSEcCtD
Propericiazine—Vomiting—Capecitabine—kidney cancer	0.000649	0.000656	CcSEcCtD
Propericiazine—Rash—Capecitabine—kidney cancer	0.000644	0.00065	CcSEcCtD
Propericiazine—Dermatitis—Capecitabine—kidney cancer	0.000643	0.00065	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—kidney cancer	0.000642	0.000649	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000636	0.000643	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—kidney cancer	0.000615	0.000621	CcSEcCtD
Propericiazine—Nausea—Capecitabine—kidney cancer	0.000606	0.000613	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—kidney cancer	0.000595	0.000601	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—kidney cancer	0.000587	0.000593	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—kidney cancer	0.000585	0.000591	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—kidney cancer	0.000563	0.000569	CcSEcCtD
Propericiazine—Fluphenazine—ABCB1—kidney cancer	0.000521	0.0495	CrCbGaD
Propericiazine—Body temperature increased—Doxorubicin—kidney cancer	0.00052	0.000526	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—kidney cancer	0.000485	0.00049	CcSEcCtD
Propericiazine—Clomipramine—ABCB1—kidney cancer	0.000476	0.0453	CrCbGaD
Propericiazine—Diarrhoea—Doxorubicin—kidney cancer	0.00045	0.000455	CcSEcCtD
Propericiazine—Promethazine—ABCB1—kidney cancer	0.000422	0.0401	CrCbGaD
Propericiazine—Vomiting—Doxorubicin—kidney cancer	0.000418	0.000423	CcSEcCtD
Propericiazine—Trifluoperazine—ABCB1—kidney cancer	0.000416	0.0396	CrCbGaD
Propericiazine—Rash—Doxorubicin—kidney cancer	0.000415	0.000419	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—kidney cancer	0.000414	0.000419	CcSEcCtD
Propericiazine—Quetiapine—ABCB1—kidney cancer	0.000404	0.0384	CrCbGaD
Propericiazine—Nausea—Doxorubicin—kidney cancer	0.000391	0.000395	CcSEcCtD
Propericiazine—Chlorpromazine—ABCB1—kidney cancer	0.000327	0.031	CrCbGaD
